This is a great description.
A group of researchers from the Autoimmune Neurology Group at the University of Oxford led by Dr. Sarosh Irani, recently published an article in the Lancet Psychiatry, noting that a focus on the psychopathology is likely the most effective way to promote prompt recognition of NMDAR-antibody encephalitis. NMDAR-antibody encephalitis is an autoantibody-mediated disease that typically presents …
Psychiatrists play a pivotal role in the diagnosis and treatment of AE. As psychiatric symptoms often dominate the symptoms that occur at onset of this disease, patients may present initially to a psychiatrist who are tasked with identifying abnormal features of psychosis presentations, including alterations in mental status, seizures, and dysautonomia, which may prompt consideration …
This is a two-day international meeting on 5-6 June 2019 for clinicians and scientists looking to appreciate the breadth of translational autoimmune neurology. This inaugural meeting will cover the clinical features of CNS and PNS diseases, methodological aspects of immunological assays, applied T and B cell pathophysiology, and questions relating to immunological tolerance. By being …
Late last year a systematic review of AE syndromes, diagnosis, and treatment was published in Frontiers in Neurology by two physicians in Austria, and reviewed by physicians in Australia and the US (Mayo Clinic). We felt it may be useful as an up-to-date reference. Once again, the importance of early recognition of AE with prompt …
A group of physicians from Germany have recently published an article in Seminars in Immunopathology, noting significant differences in the incidence of autoimmune diseases of the central nervous system in males versus females. They stated diseases such as multiple sclerosis, neuromyelitis optica and autoimmune encephalitis are more likely to be found in females. Some examples …
A study just published in the Journal of Neurology, conducted at 5 hospitals (4 Germany, 1 Austria) reported admission diagnosis in AE patients is still proving a challenge. The physicians attributed this to the fact that initial symptoms vary widely, causing the correct diagnosis to be delayed or even missed. They looked back at 50 …
We are honored to have friends at the Encephalitis Society in the UK, who provide support for the community of people who have experienced all types of encephalitis. Chief Executive, Dr. Ava Easton, has recently published an article entitled “Treating encephalitis in primary care settings” in the Independent Nurse. She provided a summary of the …
Although a majority of patients with anti-NMDA receptor encephalitis make a good recovery, it can take time for patients to recover. Physicians are often looking for objective means to assess a patient’s recovery and ways to monitor for relapses. Researchers at Northwestern and Massachusetts General recently published a case study in which they used a …
Physicians from centers in four countries collaborated on a recent retrospective study concerning the use of mycophenolate mofetil (Cell Cept) in autoimmune/immune-mediated diseases of the central nervous system in children. A large percentage of the study population were children with autoimmune encephalitis. The authors were interested in the safety of the medication and whether children …
The AE Alliance is excited to announce a groundbreaking symposium titled: “Autoimmune Encephalitis: A Bridge Between Neurology and Psychiatry.” HESA (Hashimoto’s Encephalopathy SREAT Alliance) is the initiator and lead organizer of this symposium to be held on April 6, 2019 at Weill Cornell Medical School, Cornell University in New York, NY. The April 2019 symposium for doctors …
